A workplace fitness program runs by Perry Lieber.pdf

•

0 likes•2 views

In Santa Barbara, Perry Lieber works as a trainer. His clientele is diverse and includes celebrities and athletes of various calibers, from amateur to professional. Adam Lieber is a qualified fitness and health entrepreneur with more than 16 years of experience in the health and wellness industry.

Health & Medicine

PERRY ADAM LIEBER
A happy body is a
healthy body. It
benefits your
mental and
emotional health.
Adam Lieber is a
qualified fitness
and health
entrepreneur with
more than 16 years
of experience.
HEALTH AND FITNESS
TRAINER

Recently uploaded

Fundamental of Radiobiology -SABBU.pptx

Sabbu Khatoon

RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0). CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.

Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...

Oleg Kshivets

Arterial health throughout cancer treatment and exercise rehabilitation in wo...

Catherine Liao

Is preeclampsia and spontaneous preterm delivery associate with vascular and ...

Catherine Liao

Contact dermaititis (irritant and allergic).pdf

Chulalongkorn Allergy and Clinical Immunology Research Group

"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...

Catherine Liao

i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource. This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and Associate Division Director for Ambulatory Operations The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma. STATEMENT OF NEED Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL. Target Audience Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL). Learning Objectives 1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL 2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults 3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...

i3 Health

Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx

Dr. Rabia Inam Gandapore

Non-Invasive assessment of arterial stiffness in advanced heart failure patie...

Catherine Liao

1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf

Ks doctor

Effects of vaping e-cigarettes on arterial health

Catherine Liao

Scientificity and feasibility study of non-invasive central arterial pressure...

Catherine Liao

The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...

Catherine Liao

Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx

gauripg8

5cl adbb 5cladba cheap and fine Telegram: +85297504341

Sherrylee83

Young at heart: Cardiovascular health stations to empower healthy lifestyle b...

Catherine Liao

How to Give Better Lectures: Some Tips for Doctors

LanceCatedral

Multiple sclerosis diet.230524.ppt3.pptx

MeenakshiGursamy

Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol that is rapidly distributed in the body and brain. Ethanol alters many neurochemical systems and has rewarding and addictive properties. It is the oldest recreational drug and likely contributes to more morbidity, mortality, and public health costs than all illicit drugs combined. The 5th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) integrates alcohol abuse and alcohol dependence into a single disorder called alcohol use disorder (AUD), with mild, moderate, and severe subclassifications (American Psychiatric Association, 2013). In the DSM-5, all types of substance abuse and dependence have been combined into a single substance use disorder (SUD) on a continuum from mild to severe. A diagnosis of AUD requires that at least two of the 11 DSM-5 behaviors be present within a 12-month period (mild AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria). The four main behavioral effects of AUD are impaired control over drinking, negative social consequences, risky use, and altered physiological effects (tolerance, withdrawal). This chapter presents an overview of the prevalence and harmful consequences of AUD in the U.S., the systemic nature of the disease, neurocircuitry and stages of AUD, comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and pharmacotherapies for AUD.

Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf

Dr Jeenal Mistry

Retinal consideration in cataract surgery

KafrELShiekh University

Recently uploaded (20)

Fundamental of Radiobiology -SABBU.pptx

Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...

Arterial health throughout cancer treatment and exercise rehabilitation in wo...

Is preeclampsia and spontaneous preterm delivery associate with vascular and ...

Contact dermaititis (irritant and allergic).pdf

"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...

Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx

Non-Invasive assessment of arterial stiffness in advanced heart failure patie...

1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf

Effects of vaping e-cigarettes on arterial health

Scientificity and feasibility study of non-invasive central arterial pressure...

The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...

Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx

5cl adbb 5cladba cheap and fine Telegram: +85297504341

Young at heart: Cardiovascular health stations to empower healthy lifestyle b...

How to Give Better Lectures: Some Tips for Doctors

Multiple sclerosis diet.230524.ppt3.pptx

Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf

Retinal consideration in cataract surgery